These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38214675)

  • 1. Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial.
    Fayoux P; Dinomais M; Shaw H; Villain F; Schwartz D; Rondeau S; Letellier G; Auvin S
    Dev Med Child Neurol; 2024 Jul; 66(7):910-918. PubMed ID: 38214675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.
    Fayoux P; Dinomais M; Shaw H; Probert N; Villain F; Pouchain D; Texier N; Auvin S
    BMJ Paediatr Open; 2023 May; 7(1):. PubMed ID: 37156563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycopyrronium for severe drooling in children.
    Drug Ther Bull; 2017 Aug; 55(8):93-96. PubMed ID: 28808084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
    Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
    Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
    Trials; 2014 Feb; 15():60. PubMed ID: 24533890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP
    Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
    Wang C; Sun T; Huang Y; Humphries M; Bai L; Li L; Wang Q; Kho P; Firth R; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():57-68. PubMed ID: 25609940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
    Hohlfeld JM; Vogel-Claussen J; Biller H; Berliner D; Berschneider K; Tillmann HC; Hiltl S; Bauersachs J; Welte T
    Lancet Respir Med; 2018 May; 6(5):368-378. PubMed ID: 29477448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The when, why, and how of using glycopyrronium to diminish drooling in children with neurodevelopmental disabilities: Implications for clinical practice.
    Orriëns LB; van der Burg JJW; van den Hoogen FJA; Willemsen MAAP; van Hulst K; Erasmus CE
    Eur J Paediatr Neurol; 2024 Jul; 51():24-31. PubMed ID: 38776696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
    Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel model-based approach for dose determination of glycopyrronium bromide in COPD.
    Arievich H; Overend T; Renard D; Gibbs M; Alagappan V; Looby M; Banerji D
    BMC Pulm Med; 2012 Dec; 12():74. PubMed ID: 23217058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
    Kerwin EM; Spangenthal S; Kollar C; St Rose E; Reisner C
    Respir Res; 2018 Mar; 19(1):38. PubMed ID: 29506504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycopyrrolate treatment of chronic drooling.
    Blasco PA; Stansbury JC
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study.
    Singh D; Scuri M; Collarini S; Vezzoli S; Mariotti F; Muraro A; Acerbi D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2001-2014. PubMed ID: 28744115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
    Arbouw ME; Movig KL; Koopmann M; Poels PJ; Guchelaar HJ; Egberts TC; Neef C; van Vugt JP
    Neurology; 2010 Apr; 74(15):1203-7. PubMed ID: 20385892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
    Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
    Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
    Neverlien PO; Sørumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):187-8. PubMed ID: 11475197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialorrhoea treated with inhaled glycopyrronium.
    Plunkett C
    BMJ Support Palliat Care; 2021 Dec; 11(4):406-407. PubMed ID: 32826264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.